Package 11673-100-01

{"route": ["OPHTHALMIC"], "spl_id": "0cfa0b71-d377-fa73-e063-6294a90a390e", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "unii": ["PDC6A3C0OX", "MZ1131787D"], "rxcui": ["1235200"], "spl_set_id": ["1b26cd3b-4a05-4623-b320-01f22b3106ff"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DROPPER in 1 BOX (11673-100-01)  / 15 mL in 1 BOTTLE, DROPPER", "package_ndc": "11673-100-01", "marketing_start_date": "20190208"}], "brand_name": "Target Eye Drops Maximum Redness Relief Eye", "product_id": "11673-100_0cfa0b71-d377-fa73-e063-6294a90a390e", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "11673-100", "generic_name": "Glycerin, Naphazoline hydrochloride", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Target Eye Drops Maximum Redness Relief Eye", "active_ingredients": [{"name": "GLYCERIN", "strength": "500 mg/100mL"}, {"name": "NAPHAZOLINE HYDROCHLORIDE", "strength": "30 mg/100mL"}], "application_number": "M018", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190208", "listing_expiration_date": "20261231"}